Myla Lai-Goldman
- Co-authors
- Hawazin FarukiD. Neil HayesGregory M. MayhewJonathan S. SerodyCharles M. PerouJoseph A. DiGiuseppeSteven N. GoodmanScott E. Kern
- Topics
- Drug-Induced Adverse Reactions (3 papers)Neuroendocrine Tumor Research Advances (2 papers)Autoimmune Bullous Skin Diseases (2 papers)
- Cited by
- OncologyCancer ResearchPharmacology
- Partner nations
- United States
In The Last Decade
Myla Lai-Goldman
14 papers receiving 459 citations
Peers
Comparison fields: 5 of 63
- Oncology 255
- Molecular Biology 146
- Cancer Research 115
- Pulmonary and Respiratory Medicine 94
- Epidemiology 84
Countries citing papers authored by Myla Lai-Goldman
This map shows the geographic impact of Myla Lai-Goldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Myla Lai-Goldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Myla Lai-Goldman more than expected).
Fields of papers citing papers by Myla Lai-Goldman
This network shows the impact of papers produced by Myla Lai-Goldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Myla Lai-Goldman. The network helps show where Myla Lai-Goldman may publish in the future.
Co-authorship network of co-authors of Myla Lai-Goldman
This figure shows the co-authorship network connecting the top 25 collaborators of Myla Lai-Goldman. A scholar is included among the top collaborators of Myla Lai-Goldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Myla Lai-Goldman. Myla Lai-Goldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 118 | |
| 2 | 4 | |
| 3 | 12 | |
| 4 | 30 | |
| 5 | 3 | |
| 6 | 18 | |
| 7 | 24 | |
| 8 | 150 | |
| 9 | 3 | |
| 10 | 1 | |
| 11 | The cytobrush for evaluating routine cervicovaginal-endocervical smears. | 9 |
| 12 | 67 | |
| 13 | 24 | |
| 14 | 10 |
About Myla Lai-Goldman
Myla Lai-Goldman is a scholar working on Endocrinology, Gastroenterology and Pharmacology, having authored 14 papers that have together received 473 indexed citations. Recurring topics across this work include Drug-Induced Adverse Reactions (3 papers), Neuroendocrine Tumor Research Advances (2 papers) and Autoimmune Bullous Skin Diseases (2 papers). The work is most often cited by research in Oncology (255 citations), Cancer Research (115 citations) and Pharmacology (30 citations). Myla Lai-Goldman has collaborated with scholars based in United States. Frequent co-authors include Hawazin Faruki, D. Neil Hayes, Gregory M. Mayhew, Jonathan S. Serody, Charles M. Perou, Joseph A. DiGiuseppe, Steven N. Goodman, Scott E. Kern, Ralph H. Hruban and Charles J. Yeo. Their work appears in journals such as Nucleic Acids Research, Cancer and Human Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.